HTBX - Heat Biologics expands R&D and pre-clinical capabilities

Heat Biologics (HTBX) announces the expansion of its research and development facilities in Morrisville, North Carolina.The expansion will support the addition of enhanced research and development capabilities including in-house synthesis of antibodies and other drugs/reagents as well as an expanded vivarium for onsite pre-clinical studies."By bringing more of our development and pre-clinical activities in-house, we expect to accelerate R&D timelines and generate cost savings on research and development that would have otherwise been achieved through use of third-party service providers," CEO Jeff Wolf said.

For further details see:

Heat Biologics expands R&D and pre-clinical capabilities